دورية أكاديمية
Efficacy of 0.01% atropine for myopia control in a randomized, placebo-controlled trial depends on baseline electroretinal response.
العنوان: | Efficacy of 0.01% atropine for myopia control in a randomized, placebo-controlled trial depends on baseline electroretinal response. |
---|---|
المؤلفون: | Chan HHL; Laboratory of Experimental Optometry (Neuroscience), School of Optometry, The Hong Kong Polytechnic University, 11 Yuk Choi Road, Hung Hom, Kowloon, Hong Kong. henryhl.chan@polyu.edu.hk.; Centre for Myopia Research, School of Optometry, The Hong Kong Polytechnic University, Kowloon, Hong Kong. henryhl.chan@polyu.edu.hk.; Research Centre for SHARP Vision (RCSV), The Hong Kong Polytechnic University, Kowloon, Hong Kong. henryhl.chan@polyu.edu.hk.; Centre for Eye and Vision Research Limited, 17W Hong Kong Science Park, Shatin, Hong Kong. henryhl.chan@polyu.edu.hk.; University Research Facilities in Behavioral and Systems Neuroscience (UBSN), The Hong Kong Polytechnic University, Kowloon, Hong Kong. henryhl.chan@polyu.edu.hk., Choi KY; Laboratory of Experimental Optometry (Neuroscience), School of Optometry, The Hong Kong Polytechnic University, 11 Yuk Choi Road, Hung Hom, Kowloon, Hong Kong.; Centre for Myopia Research, School of Optometry, The Hong Kong Polytechnic University, Kowloon, Hong Kong., Ng ALK; Department of Ophthalmology, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong., Choy BNK; Department of Ophthalmology, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong., Chan JCH; Department of Ophthalmology, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong., Chan SSH; Laboratory of Experimental Optometry (Neuroscience), School of Optometry, The Hong Kong Polytechnic University, 11 Yuk Choi Road, Hung Hom, Kowloon, Hong Kong.; Centre for Myopia Research, School of Optometry, The Hong Kong Polytechnic University, Kowloon, Hong Kong., Li SZC; Laboratory of Experimental Optometry (Neuroscience), School of Optometry, The Hong Kong Polytechnic University, 11 Yuk Choi Road, Hung Hom, Kowloon, Hong Kong.; Centre for Myopia Research, School of Optometry, The Hong Kong Polytechnic University, Kowloon, Hong Kong., Yu WY; Laboratory of Experimental Optometry (Neuroscience), School of Optometry, The Hong Kong Polytechnic University, 11 Yuk Choi Road, Hung Hom, Kowloon, Hong Kong. |
المصدر: | Scientific reports [Sci Rep] 2022 Jul 08; Vol. 12 (1), pp. 11588. Date of Electronic Publication: 2022 Jul 08. |
نوع المنشور: | Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
اللغة: | English |
بيانات الدورية: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE |
أسماء مطبوعة: | Original Publication: London : Nature Publishing Group, copyright 2011- |
مواضيع طبية MeSH: | Atropine* , Myopia*/drug therapy, Axial Length, Eye ; Child ; Disease Progression ; Humans ; Ophthalmic Solutions ; Refraction, Ocular ; Vision Tests |
مستخلص: | This study aimed to evaluate the efficacy of 18-month 0.01% atropine in 61 myopic children (aged 7-10) and the relationship with central retinal response (by multifocal electroretinogram [mfERG]) in a double-masked randomized placebo-controlled clinical trial. Global-flash mfERG was measured at baseline, while cycloplegic spherical equivalent refraction (SER) and axial length (AL) were measured at baseline and at 6-month intervals. Annualized change in SER and AL were compared between atropine and control groups, and the relationships with baseline mfERG were evaluated. Changes in SER (-0.70 ± 0.39D vs. -0.66 ± 0.41D, p = 0.63) and AL (0.32 ± 0.16 mm vs. 0.30 ± 0.22 mm, p = 0.52) were similar in atropine and control groups. Interestingly, in the placebo group, mfERG amplitude was negatively correlated with axial elongation (R (© 2022. The Author(s).) |
References: | Graefes Arch Clin Exp Ophthalmol. 2005 Feb;243(2):132-41. (PMID: 15742211) JAMA. 2020 Aug 11;324(6):571-580. (PMID: 32780139) Doc Ophthalmol. 2021 Jun;142(3):315-328. (PMID: 33231734) Invest Ophthalmol Vis Sci. 2012 Aug 09;53(9):5320-5. (PMID: 22761262) Doc Ophthalmol. 2008 May;116(3):165-76. (PMID: 17721791) Ophthalmology. 2021 Aug;128(8):1180-1187. (PMID: 33422558) Ophthalmology. 2006 Dec;113(12):2285-91. (PMID: 16996612) Br J Ophthalmol. 2020 Nov;104(11):1535-1541. (PMID: 32086237) Ophthalmology. 2012 Feb;119(2):347-54. (PMID: 21963266) Exp Eye Res. 2020 Nov;200:108205. (PMID: 32866531) Ophthalmology. 2019 Jan;126(1):113-124. (PMID: 30514630) Ophthalmic Physiol Opt. 2015 Sep;35(5):465-75. (PMID: 26303444) JAMA Ophthalmol. 2021 Mar 1;139(3):293-300. (PMID: 33443542) Br J Ophthalmol. 2020 Mar;104(3):363-368. (PMID: 31142465) Invest Ophthalmol Vis Sci. 2017 Aug 1;58(10):4399–4406. (PMID: 28813575) JAMA Ophthalmol. 2017 Jun 1;135(6):624-630. (PMID: 28494063) Prog Retin Eye Res. 2018 Jan;62:134-149. (PMID: 28951126) Exp Eye Res. 2018 Jul;172:104-111. (PMID: 29608907) Vision Res. 2008 Jul;48(16):1726-1734. (PMID: 18573515) Ophthalmology. 2022 Mar;129(3):308-321. (PMID: 34627809) Biochem Med (Zagreb). 2021 Feb 15;31(1):010502. (PMID: 33380887) Br J Ophthalmol. 2014 Jan;98(1):40-5. (PMID: 24169657) Br J Ophthalmol. 2021 Aug 2;:. (PMID: 34340973) Br J Ophthalmol. 2021 Mar 17;:. (PMID: 33731364) Am J Ophthalmol. 2014 Feb;157(2):451-457.e1. (PMID: 24315293) JAMA Netw Open. 2022 Jan 4;5(1):e2143781. (PMID: 35029662) Am J Ophthalmol. 2015 May;159(5):945-9. (PMID: 25640408) Ophthalmology. 2016 May;123(5):1036-42. (PMID: 26875007) Br J Ophthalmol. 2005 Feb;89(2):151-3. (PMID: 15665343) Invest Ophthalmol Vis Sci. 2012 Oct 11;53(11):7077-85. (PMID: 22969068) Invest Ophthalmol Vis Sci. 2002 May;43(5):1673-85. (PMID: 11980890) |
المشرفين على المادة: | 0 (Ophthalmic Solutions) 7C0697DR9I (Atropine) |
تواريخ الأحداث: | Date Created: 20220708 Date Completed: 20220712 Latest Revision: 20220915 |
رمز التحديث: | 20231215 |
مُعرف محوري في PubMed: | PMC9270320 |
DOI: | 10.1038/s41598-022-15686-6 |
PMID: | 35804049 |
قاعدة البيانات: | MEDLINE |
تدمد: | 2045-2322 |
---|---|
DOI: | 10.1038/s41598-022-15686-6 |